All treatments
Treatment
Ofev 150 mg soft capsules clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
Pragmatic management of progressive disease in idiopathic pulmonary fibrosis: a randomized trial. PROGRESSION-IPF
This study looks at how well different medicines treat Idiopathic Pulmonary Fibrosis (IPF). It compares two common drugs, Esbriet and Ofev, to see which helps slow down the disease’s progress and if people can take them easily. It aims to find the best ways to manage IPF.
For: idiopathic pulmonary fibrosisFrance - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A multicentre clinical trial evaluating the safety and efficacy of the combination of nintedanib and tocilizumab compared to standard treatment in patients with systemic sclerosis and interstitial lung disease. Analysis with theranostic approach and assessment of cytokine activity, markers of inflammation and pulmonary fibrosis using computed tomography, positron emission tomography, and metabolome and transcriptome studies in selected patients. NINTOC-TU study
This study looks at new ways to treat a specific lung problem called interstitial lung disease (ILD) that can happen with a condition called systemic sclerosis. It compares a new combination of medicines with standard treatment to see if it can help improve breathing and reduce symptoms.
For: systemic sclerosis with interstitial lung disease (ILD) in the course of the diseasePoland